This study assesses cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders.
This randomized trial compares the effects of metformin vs placebo on weight gain in children and adolescents with autism spectrum disorder taking atypical antipsychotics.
This 38-year longitudinal study of a representative birth cohort (the Dunedin Multidisciplinary Health and Development Study of New Zealand) tests associations between cannabis use over 20 years and a variety of physical health indexes at early midlife.
This systematic review and meta-analysis assesses type 2 diabetes mellitus risk associated with antipsychotic treatment in youth.
This randomized clinical trial shows that long-acting injectable risperidone resulted in better clinical outcomes than oral risperidone.
This population-based cohort study reports an independent association of depression and diabetes mellitus (DM) with the risk for dementia in a national population sample from medical registries. See also the Invited Commentary by Reynolds.
Umbricht and colleagues aimed to determine the efficacy and safety of bitopertin, a glycine reuptake inhibitor, in patients with schizophrenia and predominant negative symptoms who were stable while taking an antipsychotic treatment. Goff provided a related editorial.
Sullivan et al determine whether comorbid depression in patients with type 2 diabetes accelerates cognitive decline.
Proton magnetic resonance spectroscopic imaging data were acquired longitudinally for children
with autism spectrum disorder or developmental delay and primarily cross-sectionally for children
with typical development by Corrigan and coauthors to examine cross-sectional and longitudinal
patterns of brain chemical concentrations from 3 different age groups, beginning early in the